Who Owns CNSP?

CNS Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$2.28

-0.07 (-2.98%)

Market Cap

$1.7M

Shares Outstanding

574,580

Institutional Holders

7

Total Inst. Value

$55K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1UBS Group AG$33K23,978
2Ground Swell Capital, LLC$15K11,341
3Tower Research Capital LLC (TRC)$7K5,111
4BARRETT & COMPANY, INC.$136100
5MAI Capital Management$5540
6SBI Securities Co., Ltd.$2015
7BANK OF AMERICA CORP /DE/$09

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CNSP?

As of Q1 2025, 7 institutional investors report holding CNSP (CNS Pharmaceuticals, Inc.) in their 13F filings.

Which hedge fund owns the most CNSP?

The largest institutional holder of CNSP is UBS Group AG with $33K in shares.

Are institutions buying or selling CNSP?

This quarter, 3 institutions opened new positions in CNSP and 17 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.